We investigated how the accessory molecule interactions encountered during
T cell priming influence T cell-mediated destruction of insulin-producing b
eta cells and lead to type I diabetes. T cell receptor (TCR)-transgenic CD4
(+) T cells were primed under controlled conditions in vitro before being a
doptively transferred into transgenic recipients expressing membrane ovalbu
min under the control of the rat insulin promoter (RIP-mOVA), During primin
g, antigen-presenting cell expression of B7-1 without intracellular adhesio
n molecule 1 (ICAM-1) led to the generation of effector cells that migrated
to the pancreata of RIP-mOVA recipients but did not cause diabetes. In con
trast, when T cells were primed with APCs expressing both B7-1 and ICAM-1,
pronounced destruction of beta cells and a rapid onset of diabetes were obs
erved. Pathogenicity was associated with T cell production of the macrophag
e-attracting chemokines CCL3 and CCL4. Thus, interactions of lymphocyte fun
ction-associated antigen 1 with ICAM-1 during priming induce both qualitati
ve and quantitative alterations in T effector function and induce potential
ly autodestructive responses.